Report : A-Z CDF items in Formulary 03/03/2021 11:47:37

[Back]

Section Status CDF Name 08.02.04 Formulary Atezolizumab  (Tecentriq®) 08.02.04 Formulary Avelumab  (Bavencio®) 08.02.04 Formulary Axicabtagene ciloleuce (Yescarta®) 08.01.01 Formulary Bendamustine  08.01.05 Formulary Bevacizumab Avastin® 08.02 Formulary Blinatumomab Blincyto® 08.01.05 Formulary Bortezomib Velcade® 08.01.05 Formulary Bosutinib Bosulif® 08.01.05 Formulary Brentuximab vedotin Adcetris® 08.01.05 Formulary Cabozantinib Cabometyx® 08.01 Formulary Cemiplimab Libtayo® 08.01.05 Formulary Cetuximab Erbitux® 08.01.03 Formulary Clofarabine Evoltra® 08.01.05 Formulary Crizotinib Xalkori® 08.01.05 Formulary Dabrafenib Tafinlar® 08.01.05 Formulary Dacomitinib Vizimpro®) 08.02.04 Formulary Daratumumab  (Darzalex®) 08.01.05 Restricted Use Dasatinib Sprycel® 08.02.04 Formulary Dinutuximab  (Qarziba®) 08.01.02 Formulary Doxorubicin Caelyx® 08.02.04 Formulary Durvalumab   (Imfinzi® ) 08.01.05 Formulary Eribulin Halaven® 08.01.05 Restricted Use Everolimus Afinitor® 08.02.04 Formulary Glatiramer Acetate Copaxone® 08.01.05 Formulary Ibrutinib Imbruvica® 08.02.04 Formulary Immunocellular therapy containing tisagenlecleucel, autologous T cells genetically modified ex vivo using a lentiviral vector encoding an anti-CD19 chimeric antigen receptor (CAR) (Kymriah®) 08.01 Formulary Inotuzumab ozogamicin Besponsa® 08.01.05 Formulary Ipilimumab Yervoy® 08.01.05 Formulary Ixazomib Ninlaro® 08.02.04 Formulary Lenalidomide  08.01.03 Formulary Nelarabine Atriance® 08.01.05 Formulary Neratinib  08.02.04 Formulary Niraparib (Zejula®) 08.02.04 Formulary Nivolumab Opdivo® 08.02.04 Formulary Osimertinib Tagrisso 08.01.05 Formulary Panitumumab Vectibix® 08.01.05 Formulary Pembrolizumab Keytruda® 08.01.03 Formulary Pemetrexed Alimta® 08.02.04 Formulary Pemrolizumab Keytruda® 08.01.05 Formulary Pertuzumab Perjeta® 08.02.04 Formulary Pomalidomide Imnovid® 08.01.05 Formulary Ponatinib Iclusig® 08.03.04.02 Formulary Radium-223 dichloride  08.01.05 Formulary Regorafenib Stivarga® 08.01.05 Formulary Ribociclib  08.01.05 Formulary Rucaparib  08.01.05 Formulary Sorafenib Nexavar® 08.01.05 Formulary Sunitinib Sutent® 08.02.04 Formulary Talimogene laherparepvac Imlygic® 08.01.05 Formulary Temsirolimus Torisel® 08.02.04 Formulary Teriflunomide Aubagio® 08.01.05 Formulary Trametinib Mekinist® 08.01.05 Formulary Trastuzumab emtansine Kadcyla® 08.01.05 Formulary Trifluridine and Tipiracil  Lonsurf ® 08.01.05 Formulary Venetoclax Venclyxto ®

Northern Lincolnshire